These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 3185292

  • 21. Oestradiol: the predominant intranuclear oestrogen in the endometrium of oestrogen-treated postmenopausal women.
    Whitehead MI, Lane G, Dyer G, Townsend PT, Collins WP, King RJ.
    Br J Obstet Gynaecol; 1981 Sep; 88(9):914-8. PubMed ID: 7272264
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Effects of conjugated equine oestrogens and oestriol on blood clotting, plasma lipids and endometrial proliferation in post-menopausal women.
    Campagnoli C, Tousijn LP, Belforte P, Ferruzzi L, Dolfin AM, Morra G.
    Maturitas; 1981 Aug; 3(2):135-44. PubMed ID: 6270507
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Osteoporosis prevention clinical study program.
    Delmas P, Gimona A.
    Eur J Obstet Gynecol Reprod Biol; 1996 Apr; 64 Suppl():S39-45. PubMed ID: 8732473
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. The effect of hormone replacement therapy on the oxidation of low density lipoprotein in postmenopausal women.
    Mc Manus J, Mc Eneny J, Thompson W, Young IS.
    Atherosclerosis; 1997 Nov; 135(1):73-81. PubMed ID: 9395275
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Metabolic effects of oestrogens: impact of the route of administration.
    Ho KK, O'Sullivan AJ, Wolthers T, Leung KC.
    Ann Endocrinol (Paris); 2003 Apr; 64(2):170-7. PubMed ID: 12773957
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Endometrial and menstrual response to subcutaneous oestradiol and testosterone implants and continuous oral progestogen therapy in post-menopausal women.
    Magos AL, Brincat M, O'Dowd T, Wardle PJ, Schlesinger P, Studd JW.
    Maturitas; 1985 Nov; 7(4):297-302. PubMed ID: 4079826
    [Abstract] [Full Text] [Related]

  • 39. Oestrogens, gonadotrophins and SHBG during oral and cutaneous administration of oestradiol-17 beta to menopausal women.
    Fåhraeus L, Larsson-Cohn U.
    Acta Endocrinol (Copenh); 1982 Dec; 101(4):592-6. PubMed ID: 6818806
    [Abstract] [Full Text] [Related]

  • 40. Serum levels of oestrogens, progesterone, follicle-stimulating hormone and sex-hormone-binding globulin during simultaneous vaginal administration of 17 beta-oestradiol and progesterone in the pre- and post-menopause.
    Carlström K, Pschera H, Lunell NO.
    Maturitas; 1988 Dec; 10(4):307-16. PubMed ID: 3147360
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.